139 related articles for article (PubMed ID: 37663709)
41. Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.
Groblewska M; Mroczko B; Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kędra B; Kemona A; Szmitkowski M
Tumour Biol; 2014 Apr; 35(4):3793-802. PubMed ID: 24395652
[TBL] [Abstract][Full Text] [Related]
42. Synergistic efficacy of Cullin1 and MMP-2 expressions in diagnosis and prognosis of colorectal cancer.
Deng J; Chen W; Du Y; Wang W; Zhang G; Tang Y; Qian Z; Xu P; Cao Z; Zhou Y
Cancer Biomark; 2017; 19(1):57-64. PubMed ID: 28269751
[TBL] [Abstract][Full Text] [Related]
43. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9.
Wang W; Li D; Xiang L; Lv M; Tao L; Ni T; Deng J; Gu X; Masatara S; Liu Y; Zhou Y
Cell Adh Migr; 2019 Dec; 13(1):273-284. PubMed ID: 31293204
[TBL] [Abstract][Full Text] [Related]
44. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Yamada T; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Inagaki D; Yamamoto N; Sato T; Fujii S; Numata K; Kunisaki C; Shiozawa M; Morinaga S; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Anticancer Res; 2010 Jul; 30(7):2693-9. PubMed ID: 20683000
[TBL] [Abstract][Full Text] [Related]
46. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
[TBL] [Abstract][Full Text] [Related]
47. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Wang WS; Chen PM; Wang HS; Liang WY; Su Y
Carcinogenesis; 2006 May; 27(5):1113-20. PubMed ID: 16474169
[TBL] [Abstract][Full Text] [Related]
48. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
Leinonen T; Pirinen R; Böhm J; Johansson R; Ropponen K; Kosma VM
Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426
[TBL] [Abstract][Full Text] [Related]
49. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.
Morán A; Iniesta P; García-Aranda C; De Juan C; Díaz-López A; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Balibrea JL; Benito M
Oncol Rep; 2005 Jan; 13(1):115-20. PubMed ID: 15583811
[TBL] [Abstract][Full Text] [Related]
50. [Expression of LOX in Colorectal Cancer Tissues and Its Relationship with Progress and Prognosis].
Shi XM; Zhao W; Yang YB; Lü BN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):566-569. PubMed ID: 29130678
[TBL] [Abstract][Full Text] [Related]
51. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
[TBL] [Abstract][Full Text] [Related]
52. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
[TBL] [Abstract][Full Text] [Related]
53. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
Kang JC; Chen JS; Lee CH; Chang JJ; Shieh YS
J Surg Oncol; 2010 Sep; 102(3):242-8. PubMed ID: 20740582
[TBL] [Abstract][Full Text] [Related]
54. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.
Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y
Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785
[TBL] [Abstract][Full Text] [Related]
55. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
56. The Association of Simultaneous Increase in Interleukin-6, C Reactive Protein, and Matrix Metalloproteinase-9 Serum Levels with Increasing Stages of Colorectal Cancer.
Rasic I; Rebic V; Rasic A; Aksamija G; Radovic S
J Oncol; 2018; 2018():2830503. PubMed ID: 30154846
[TBL] [Abstract][Full Text] [Related]
57. Impact of Matrix Metalloproteinase-8 Genotypes on Colorectal Cancer Risk in Taiwan.
Deng Y; Ke TW; Wang YC; Chin YT; Yueh TC; Hung YC; Mong MC; Yang YC; Chang WS; Shen TC; Bau DT; Tsai CW
Anticancer Res; 2023 Sep; 43(9):3979-3985. PubMed ID: 37648297
[TBL] [Abstract][Full Text] [Related]
58. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Gao M; Zhang X; Li D; He P; Tian W; Zeng B
Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
[TBL] [Abstract][Full Text] [Related]
59. Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
An S; Kim SK; Kwon HY; Kim CS; Bang HJ; Do H; Kim B; Kim K; Kim Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511338
[TBL] [Abstract][Full Text] [Related]
60. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
Fan YZ; Li XP; Liu WF; Li GM
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
